by HTLV | May 3, 2022 | News
Thank you for taking part in the Covid 19-HTLV patient surveySo far, 24 of you have responded:* 13 of you are from UK* 6 of you are from USA, 1 each from Canada, Brazil and Costa Rica
by HTLV | May 3, 2022 | News
HTLV-Covid19 CLINICIAN Survey If you are a clinician managing those with HTLV infection, and would like to know more about rates and outcomes of co-infection with SARS CoV-2 globally in those with HTLV, please contact divya.dhasmana@nhs.net . You...
by HTLV | May 3, 2022 | News
Dear Colleagues, With sadness and sorrow, I mourn for Prof. Umberto Bertazzoni who passed away on Sunday July 5, 2020 at the age of 82. Umberto leaves behind his wife Maria Rosa, the daughters Giovanna and Paola, and a son Lorenzo. Although he was on retirement from...
by HTLV | May 3, 2022 | News
Dear colleagues, Dear friends, The HTLV field has lost a brilliant scientist, an exemplar of scientific mentoring, a builder of bridges in research, a wonderful colleague and a true friend, as we are mourning the loss of Renaud Mahieux. I am forwarding the...
by HTLV | May 3, 2022 | News
Dear colleagues, I am deeply saddened to have to let you know of the passing of our longtime colleague, mentor and friend, Thomas A. Waldmann, M.D., Chief Emeritus of the Lymphoid Malignancies Branch and NIH Distinguished Investigator. The words...
by HTLV | May 3, 2022 | News
Dear IRVA Members, I hope this message finds you well. I am sure you recall this paragraph in our letter: Time to eradicate HTLV-1: an open letter to WHO “…..Despite its distinct etiology and distinctive pattern there is no International...
